ClinicalTrials.gg
CompletedNCT03260075Updated Nov 7, 2018

Effects of Ward Cats in Patients With Substance Abuse, Depression and Psychosis at UPK Basel

An observational study in Satisfaction and Station Atmosphere, sponsored by Swiss Tropical & Public Health Institute. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-07.

Sponsored by Swiss Tropical & Public Health Institute · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
388
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to explore the relationship between ward cats and patient satisfaction and stations atmosphere in patients with substance abuse, depression and psychosis. Moreover, we wanted to investigate the patients perception of the ward cats and the relationship between station atmosphere perceived by the employees working wards with and without cat at UKP Basel.

Read the detailed description

The following tools were used to address these aims:

  • Available MüPF data regarding patient satisfaction of 170 inpatients during 2016 was analyzed.
  • Available MüPF data regarding patient satisfaction of 151 inpatients during 2017 was analyzed.
  • 33 patients were interviewed regarding their perception of the cats
  • 30 staff members at the wards filled in questionnaires regarding station atmosphere (EssenCES)
02

Conditions studied

  • Satisfaction
  • Station Atmosphere

Browse trials for

03

In context

Personal Satisfaction

541 studies on the registry are indexed under Personal Satisfaction; 93 are open to participants now.

This study's enrollment of 388 is above the median of 180 across 115 observational studies indexed under Personal Satisfaction.

Browse Personal Satisfaction studies →

Lead sponsor

Swiss Tropical & Public Health Institute is the lead sponsor of 58 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Inpatients at UPK Basel diagnosed with substance abuse, depression and psychosis as well as staff members working at these wards.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inpatient of the 7 wards at UPK Basel diagnosed with substance abuse, depression and psychosis
  • staff working at these wards

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
388 participants (actual)
Patient registry
No

Groups and cohorts

  • ward cat

    Patients and staff at wards that have a cat present

    Other: cat

  • no ward cat

    Patients and staff at wards that have no cat present

Interventions

  • Othercat

    Cat living at the ward

06

What researchers measure

Primary outcomes

  1. Patient satisfaction (MüPF)

    Questionnaire MüPF 27

    Time frame: August - Sept 2017

Secondary outcomes

  1. station atmosphere

    Questionnaire EssenCES filled out by staff members

    Time frame: August - Sept 2017

  2. Patient satisfaction (interview)

    Patients ratings of satisfaction is assessed in a semi-structured interview

    Time frame: August - Sept 2017

  3. Patients perception of cats

    Patients perception of cats is assessed in a semi-structured interview

    Time frame: August - Sept 2017

07

Study locations

1 site
  • Universitäre Psychiatrische Kliniken Basel
    Basel, 4002, Switzerland
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03260075
Lead sponsor
Swiss Tropical & Public Health Institute
Responsible party
Sponsor
First posted
Aug 24, 2017
Start date
Jun 1, 2017
Primary completion
Dec 15, 2017
Completion
Dec 15, 2017
Last update
Nov 7, 2018

Study contacts

Karin Hediger, Dr.
principal investigator · University of Basel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion